| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) | 
|---|
| 01/09/1997 | WO1997000941A2 Novel system for multilayer growth of anchorage-dependent cells | 
| 01/09/1997 | WO1997000888A1 Methods for reducing background binding in antibody preparations | 
| 01/09/1997 | WO1997000698A1 Inhibition of hepatitis b replication | 
| 01/09/1997 | WO1997000695A1 Haemopoietic growth factor antagonists and uses therefor | 
| 01/09/1997 | WO1996038560A3 Genetic control of flowering | 
| 01/09/1997 | WO1996030540A3 Substrates for beta-lactamase and uses thereof | 
| 01/09/1997 | CA2225600A1 Gibberellin-regulated myb polypepetides | 
| 01/09/1997 | CA2225517A1 Haemopoietic growth factor antagonists and uses therefor | 
| 01/09/1997 | CA2225460A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors | 
| 01/09/1997 | CA2224995A1 Antigen non-specific glycosylation inhibiting factor derivatives | 
| 01/09/1997 | CA2224799A1 A human edg-2 receptor homolog | 
| 01/09/1997 | CA2224797A1 Immortalized epithelial tumor cell | 
| 01/09/1997 | CA2224687A1 Methods for reducing background binding in antibody preparations | 
| 01/09/1997 | CA2224477A1 Inhibition of hepatitis b replication | 
| 01/09/1997 | CA2224247A1 Human homolog of the mouse rab18 gene | 
| 01/09/1997 | CA2222270A1 Recombinant adenoviruses, use thereof for preparing aavs, complementary cell line, and pharmaceutical compositions containing said adenoviruses | 
| 01/08/1997 | EP0752248A1 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma | 
| 01/08/1997 | EP0752104A1 Differential expansion of fetal stem cells in the maternal circulation for use in prenatal genetic analysis | 
| 01/08/1997 | EP0752004A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) | 
| 01/08/1997 | EP0752003A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity | 
| 01/08/1997 | EP0751996A1 Luciferases | 
| 01/08/1997 | EP0751995A1 Riboflavin synthesis in fungi | 
| 01/08/1997 | EP0751992A1 Vascular endothelial growth factor 2 | 
| 01/08/1997 | EP0751988A1 Highly efficient production and isolation of viral particles | 
| 01/08/1997 | EP0751962A1 Methods and compositions for inhibiting cd14 mediated cell activation | 
| 01/08/1997 | EP0751957A1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases | 
| 01/08/1997 | EP0751955A1 Super proteins including interferons and interleukins | 
| 01/08/1997 | EP0751951A1 Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects | 
| 01/08/1997 | EP0751784A1 Thyroxin-binding proteins | 
| 01/08/1997 | EP0751780A1 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods | 
| 01/08/1997 | EP0751709A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases | 
| 01/08/1997 | EP0706320B1 Method of controlling insects | 
| 01/08/1997 | EP0497828B1 A process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins | 
| 01/08/1997 | EP0473724B1 A human cytokine, interleukin-9 | 
| 01/08/1997 | EP0386166B1 PROTAMINE-REACTIVE IgM ANTIBODIES | 
| 01/08/1997 | CN1139955A Human kunitz-type protease inhibitors | 
| 01/08/1997 | CN1139871A Novel apopotsis-modulating proteins, DNA encoding the proteins and methods of use thereof | 
| 01/08/1997 | CN1139703A Polypeptide for expressing virus of pig reproduction and respiration syndrome in same cell | 
| 01/08/1997 | CN1033760C Protein with 8th activity factor, process for its preparation using genetic engineering cell and pharmaceutical composition containing it | 
| 01/07/1997 | US5591828 Genetic engineering | 
| 01/07/1997 | US5591822 Hydrophobic attachment site for adhesion peptides | 
| 01/07/1997 | US5591639 Plasmids and gene expression for dna sequences | 
| 01/07/1997 | US5591629 Monoclonal antibodies which promote central nervous system remyelination | 
| 01/07/1997 | US5591627 Circulation of cell medium over substrate with patterns of adhesive such as collagen | 
| 01/07/1997 | US5591624 Retroviral packaging cell lines | 
| 01/07/1997 | US5591623 Oligonucleotide modulation of cell adhesion | 
| 01/07/1997 | US5591620 Methods of detecting and isolating a ripening form of a polypeptide having rhamnogalacturonase activity | 
| 01/07/1997 | US5591616 Method for transforming monocotyledons | 
| 01/07/1997 | US5591602 Nucleic acid encoding opioid receptor | 
| 01/07/1997 | US5591598 Method for quantitating hydrazide groups | 
| 01/07/1997 | US5591593 Peptide sequence which binds to a mucin expressed by an epithelial tumor | 
| 01/07/1997 | US5591579 Indicator cell line for detecting RNA viruses and method therefor | 
| 01/07/1997 | US5591444 Use of autologous dermal fibroblasts for the repair of skin and soft tissue defects | 
| 01/07/1997 | US5591440 Hepatitis B Virus mutants, reagents and methods for detection | 
| 01/07/1997 | CA1338829C Superior mammalian expression system | 
| 01/07/1997 | CA1338827C Fruit-specific transcriptional factors | 
| 01/03/1997 | WO1997000326A1 Packaging systems for human recombinant adenovirus to be used in gene therapy | 
| 01/03/1997 | WO1997000319A2 Chimeric leptin fused to immunoglobulin domain and use | 
| 01/03/1997 | WO1997000316A1 A process for producing trypsin (trypsinogen) | 
| 01/03/1997 | WO1996037621A3 Multimeric proteins | 
| 01/03/1997 | CA2224646A1 Chimeric leptin fused to immunoglobulin domain and use | 
| 01/02/1997 | EP0751217A2 Enhancing keratinocyte migration with clostridiopeptidase-A-collagenase | 
| 01/02/1997 | EP0751147A1 Toxoplasma gondii antigen, its production and use | 
| 01/02/1997 | EP0750679A1 Isolated, tyrosinase derived peptides and uses thereof | 
| 01/02/1997 | EP0750676A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf) | 
| 01/02/1997 | EP0750674A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-$g(b)) | 
| 01/02/1997 | EP0750673A1 Transgenic production of oligosaccharides and glycoconjugates | 
| 01/02/1997 | EP0750672A1 Dna sequences for matrix metalloproteases, their production and use | 
| 01/02/1997 | EP0750671A1 Transgenic animals producing oligosaccharides and glycoconjugates | 
| 01/02/1997 | EP0750664A1 Reproduction and utilization of functional human tissue | 
| 01/02/1997 | EP0750626A1 Corpuscles of stannius protein, stanniocalcin | 
| 01/02/1997 | EP0750516A1 Method of inhibiting the proliferation and causing the differentiation of cells with igf-1 receptor antisense oligonucleotides | 
| 01/02/1997 | EP0750505A1 Immunotherapy of cancer with allogeneic lymphocytes | 
| 01/02/1997 | EP0750503A1 Ribozyme therapy for restenosis | 
| 01/02/1997 | EP0750458A1 Terminal complement inhibitor fusion genes and proteins | 
| 01/02/1997 | EP0750457A1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells | 
| 01/02/1997 | EP0691806A4 Method of causing somatic hybridization between two species of algae | 
| 01/02/1997 | EP0556345B1 Retroviral vectors useful for gene therapy | 
| 01/02/1997 | DE19526386C1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them | 
| 01/01/1997 | CN1139455A Thrombin mutants | 
| 01/01/1997 | CN1139115A Anti-aV-integrin monoclonal antibody | 
| 12/31/1996 | US5589624 Antifungal polypeptide and process for its production | 
| 12/31/1996 | US5589621 Transformed plant cell | 
| 12/31/1996 | US5589620 Isolated from plants; useful in transforming vectors, host organisms and plants; produce plants which exhibit an increased resistance towards pests | 
| 12/31/1996 | US5589619 Increasing the amount of a gene encoding a polypeptide having hmg-coa reductase activity | 
| 12/31/1996 | US5589614 Plant-derived glutathione-S-transferase isoform II promoter | 
| 12/31/1996 | US5589610 Stamen-specific promoters from corn | 
| 12/31/1996 | US5589582 Polynucleotides en coding porcine cytokines | 
| 12/31/1996 | US5589573 Amino acid sequences of anti-idiotypic antibodies against anti-cancer human monoclonal antibody, and DNA base sequences encoding those sequences | 
| 12/31/1996 | US5589384 Formation of pentamer complex and binding to gangliosides and hinges of glycineproline and antigens or epitopes | 
| 12/31/1996 | US5589379 Geminivirus-based gene expression system | 
| 12/31/1996 | US5589377 Cells and genetic engineering | 
| 12/31/1996 | US5589376 Cloning, transplanting | 
| 12/31/1996 | US5589374 Diabetogene rad: a type II diabetes specific gene | 
| 12/31/1996 | US5589369 Cells homozygous for disrupted target loci | 
| 12/31/1996 | US5589345 Leukemia cells | 
| 12/31/1996 | US5589338 Nucleic acids encoding a mutant form of human serum albumin involved in familial dysalbuminemic hyperthyroxinemia | 
| 12/31/1996 | US5589334 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor which is processed to an antigen presented by HLA-B44, and uses thereof | 
| 12/31/1996 | US5589112 Constructing a high density cell culture system | 
| 12/31/1996 | US5589047 Using dielectrophoresis for genetic engineering |